Back to Search
PAUL YAMAUCHI, M.D., PHD
M.D., PHD
Dermatology Physician
NPI: 1720074537IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
A53239(CA)
Education
CLVLND CLINIC LERNER COLLEGE OF MED OF CASE WSTN RSV UNIVERSITY
Class of 1991
Research & Publications (20)
Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis.
PMID 18211500·Int J Dermatol·2008
8-other
The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.
PMID 15450340·Dermatol Clin·2004
4-observational
Current systemic therapies for psoriasis: where are we now?
PMID 12894129·J Am Acad Dermatol·2003
6-review
Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing.
PMID 15545098·J Cosmet Laser Ther·2004
3-trial
Idiopathic CD4+T-cell lymphocytopenia associated with vitiligo.
PMID 12004324·J Am Acad Dermatol·2002
5-case
Treatment of port wine stains using the pulsed-dye laser at 585 nm with the dynamic cooling device.
PMID 11446090·J Cutan Laser Ther·2000
5-case
A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
PMID 10903757·J Immunol·2000
8-other
Rapidly growing squamous cell carcinoma from permanent makeup tattoo.
PMID 19467384·J Am Acad Dermatol·2009
5-case
Adalimumab treats psoriasis in patients previously treated with etanercept: a case series.
PMID 19539861·J Am Acad Dermatol·2009
8-other
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
PMID 18503600·Br J Dermatol·2008
2-rct
Current and emerging therapeutic modalities for hyperhidrosis, part 2: moderately invasive and invasive procedures.
PMID 17500375·Cutis·2007
6-review
Current and emerging therapeutic modalities for hyperhidrosis, part 1: conservative and noninvasive treatments.
PMID 17674587·Cutis·2007
6-review
Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept.
PMID 16488324·J Am Acad Dermatol·2006
5-case
Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.
PMID 16488328·J Am Acad Dermatol·2006
8-other
Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.
PMID 16702497·Arch Dermatol·2006
4-observational
Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept.
PMID 16488323·J Am Acad Dermatol·2006
5-case
An assessment of traditional and novel therapies for cellulite.
PMID 16020209·J Cosmet Laser Ther·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2001 SANTA MONICA BLVD, #1160W
SANTA MONICA, CA 90404 - Phone
- (310) 829-4104
Quick Facts
- NPI
- 1720074537
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile